Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$71.97−1.66 (-2.25%)
Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –
Utah Medical Products operating margin
Operating margin is operating income as a percentage of revenue.
Utah Medical Products's operating margin for the twelve months ending Sep 30, 2026 was 29.9%. For fiscal 2025 it was 29.6%, against 33.2% the year before. The highest annual figure on record is 45.9% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.6% | −3.6 |
| FY2024 | Dec 31, 2024 | 33.2% | −0.2 |
| FY2023 | Dec 31, 2023 | 33.4% | −4.4 |
| FY2022 | Dec 31, 2022 | 37.9% | −0.6 |
| FY2021 | Dec 31, 2021 | 38.5% | +6.0 |
| FY2020 | Dec 31, 2020 | 32.5% | −5.1 |
| FY2019 | Dec 31, 2019 | 37.6% | −6.9 |
| FY2018 | Dec 31, 2018 | 44.5% | −1.4 |
| FY2017 | Dec 31, 2017 | 45.9% | +4.7 |
| FY2016 | Dec 31, 2016 | 41.2% | +2.2 |
| FY2015 | Dec 31, 2015 | 39.0% | −0.3 |
| FY2014 | Dec 31, 2014 | 39.3% | +2.6 |
| FY2013 | Dec 31, 2013 | 36.6% | +0.0 |
| FY2012 | Dec 31, 2012 | 36.6% | +5.3 |
| FY2011 | Dec 31, 2011 | 31.3% | −4.2 |
| FY2010 | Dec 31, 2010 | 35.5% | −0.9 |
| FY2009 | Dec 31, 2009 | 36.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 32.4% | +5.8 |
| Q2 FY2026 | Jun 30, 2026 | 31.1% | −1.1 |
| Q1 FY2026 | Mar 31, 2026 | 29.4% | −3.1 |
| Q4 FY2025 | Dec 31, 2025 | 27.0% | −5.0 |
| Q3 FY2025 | Sep 30, 2025 | 26.6% | −5.1 |
| Q2 FY2025 | Jun 30, 2025 | 32.1% | −2.3 |
| Q1 FY2025 | Mar 31, 2025 | 32.5% | −3.0 |
| Q4 FY2023 | Dec 31, 2023 | 32.0% | −5.4 |
| Q3 FY2023 | Sep 30, 2023 | 31.7% | −7.9 |
| Q2 FY2023 | Jun 30, 2023 | 34.4% | −3.3 |
| Q1 FY2023 | Mar 31, 2023 | 35.5% | −1.2 |
| Q4 FY2022 | Dec 31, 2022 | 37.3% | −2.4 |
| Q3 FY2022 | Sep 30, 2022 | 39.7% | −0.9 |
| Q2 FY2022 | Jun 30, 2022 | 37.7% | −0.1 |
| Q1 FY2022 | Mar 31, 2022 | 36.7% | +1.2 |
| Q4 FY2021 | Dec 31, 2021 | 39.7% | +4.1 |
| Q3 FY2021 | Sep 30, 2021 | 40.6% | +6.3 |
| Q2 FY2021 | Jun 30, 2021 | 37.8% | +15.3 |
| Q1 FY2021 | Mar 31, 2021 | 35.5% | +0.0 |
| Q4 FY2020 | Dec 31, 2020 | 35.6% | −3.9 |
| Q3 FY2020 | Sep 30, 2020 | 34.2% | −0.8 |
| Q2 FY2020 | Jun 30, 2020 | 22.5% | −15.3 |
| Q1 FY2020 | Mar 31, 2020 | 35.4% | −2.8 |
| Q4 FY2019 | Dec 31, 2019 | 39.5% | −4.2 |
| Q3 FY2019 | Sep 30, 2019 | 35.0% | −7.4 |
| Q2 FY2019 | Jun 30, 2019 | 37.8% | −8.3 |
| Q1 FY2019 | Mar 31, 2019 | 38.2% | −7.4 |
| Q4 FY2018 | Dec 31, 2018 | 43.7% | −1.1 |
| Q3 FY2018 | Sep 30, 2018 | 42.4% | −3.8 |
| Q2 FY2018 | Jun 30, 2018 | 46.1% | −0.4 |
| Q1 FY2018 | Mar 31, 2018 | 45.7% | −0.4 |
| Q4 FY2017 | Dec 31, 2017 | 44.8% | +3.9 |
| Q3 FY2017 | Sep 30, 2017 | 46.2% | +5.4 |
| Q2 FY2017 | Jun 30, 2017 | 46.5% | +5.4 |
| Q1 FY2017 | Mar 31, 2017 | 46.1% | +4.2 |
| Q4 FY2016 | Dec 31, 2016 | 40.9% | – |
| Q3 FY2016 | Sep 30, 2016 | 40.8% | – |
| Q2 FY2016 | Jun 30, 2016 | 41.1% | – |
| Q1 FY2016 | Mar 31, 2016 | 41.9% | – |
See a number that looks wrong?